Additional file 1: of Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)

Figure S1. Showing study design, Table S1. Presenting independent ethics committees (IECs) or institutional review boards (IRB) by study center, Table S2. Presenting a summary of observed efficacy data at week 52 among patients randomized to secukinumab at baseline, Table S3. Presenting patient-reported acceptability of the autoinjector, and Table S4. Presenting SAEs by SOC reported across the entire study period. (DOCX 438 kb)